Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.
published in: Journal of Clinical Oncology
date of publication: 2014-06-30
language: English
main subject: oxaliplatin, pancreatic cancer, fluorouracil
Cites articles
There is nothing here
Article - wd:Q52875756